Published in Gene Therapy Weekly, September 7th, 2006
It tricks the body into thinking this protein is foreign and infectious, which alerts killer immune cells. The same kind of strategy is producing promising results in clinical trials at M. D. Anderson of vaccines for advanced myeloid leukemia as well as other forms of leukemia, aggressive lymphoma and melanoma.
Because of the preliminary nature of therapeutic cancer vaccines - none has yet been approved for use anywhere in the world - researchers can only describe their...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-09-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.